id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-M-2886-0002,FDA,FDA-2018-M-2886,"Medical Devices; Availability of Safety and Effectiveness Summaries for
Premarket Approval Applications",Notice,Notice of Publication,2018-11-16T05:00:00Z,2018,11,2018-11-16T05:00:00Z,,2018-11-16T16:35:06Z,2018-25071,0,0,09000064838e09a0
FDA-2018-M-2886-0001,FDA,FDA-2018-M-2886,Premarket Approval Response from FDA CDRH to Abbott Diabetes Care Inc.,Other,Approval,2018-08-01T04:00:00Z,2018,8,2018-08-01T04:00:00Z,,2018-08-01T14:45:47Z,,0,0,09000064835af752